HES5 and hepatocellular carcinoma: As ROS accumulation represents a key pathophysiological process and a driving force in NAFLD and the development of HCC is the ultimate consequence of NAFLD, it is tempting to speculate that enhancing HES5 activity may attenuate NAFLD pathogenesis in vivo.